Budesonide
Eohilia, PULMICORT, PULMICORT FLEXHALER, PULMICORT RESPULES, Tarpeyo, Uceris
Corticosteroid
NADAC/unit
$0.5154
No Shortage
Tier 1: 106.4%
PA Req: 359.0%
15 Manufacturers
23 ANDAs
Budesonide reduces inflammation and suppresses immune responses, used across many conditions.
vs. brand Eohilia: Generic saves up to 95% per unit
Market Intelligence
2025-07-30 Class II Recall: Cipla USA, Inc.
2024-02-07 Class II Recall: Teva Pharmaceuticals USA, Inc
Generic Manufacturers
ACTAVIS LABORATORIES FL INCAMNEAL PHARMACEUTICALS OF NEW YORK LLCASTRAZENECA PHARMACEUTICALS LPAUROBINDO PHARMA USA INCCALLIDITAS THERAPEUTICS ABCHEPLAPHARM ARZNEIMITTEL GMBHCIPLA LTDDR REDDYS LABORATORIES SAEUGIA PHARMA SPECIALITIES LTDIMPAX LABORATORIES INCLUPIN INCMYLAN PHARMACEUTICALS INCNEPHRON PHARMACEUTICALS CORPORATIONPADAGIS ISRAEL PHARMACEUTICALS LTDPADAGIS US LLCRISING PHARMA HOLDINGS INCSALIX PHARMACEUTICALS INCSUN PHARMACEUTICAL INDUSTRIES LTDTAKEDA PHARMACEUTICALS USA INCTEVA PHARMACEUTICALS USAZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.